Scientific Questions: 6MWT and Leadless Pacemakers in Elderly Patients
Research Context: Investigation of how the 6-minute walk test (6MWT) can assist in managing impedance, fibrosis, and battery life in patients over 70 years old with single chamber leadless pacemakers (LP).
Question 1:
How does baseline 6MWT performance correlate with lead impedance stability over time in elderly patients with single chamber leadless pacemakers, and can pre-implantation exercise capacity predict optimal device positioning to minimize impedance fluctuations?
Question 2:
What is the relationship between 6MWT distance improvement post-implantation and the development of myocardial fibrosis around the leadless pacemaker electrode in patients aged 70 and above, as assessed by cardiac MRI and biomarkers?
Question 3:
Can serial 6MWT assessments be used as a non-invasive predictor of battery longevity in single chamber leadless pacemakers by correlating exercise-induced heart rate response patterns with energy consumption algorithms in elderly patients?
Question 4:
How do changes in 6MWT performance over 12-month follow-up periods reflect the progression of peri-device fibrosis and its impact on pacing thresholds and impedance measurements in geriatric populations with leadless pacemakers?
Question 5:
What is the optimal frequency of 6MWT monitoring to detect early signs of device-related complications (impedance rise, threshold elevation due to fibrosis) that could affect battery life, and how does this monitoring strategy compare to traditional device interrogation in patients over 70 with single chamber leadless pacemakers?